Ligand validation:6EHH

2GE: N~4~-cyclopropyl-6-(2,3-dichlorophenyl)pyrimidine-2,4-diamine

2GE is a Ligand Of Interest in 6EHH designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6EHH_2GE_C_201	72%	13%	0.121	0.944	2.08	1.91	7	6	0	0	100%	1
6EHH_2GE_D_201	69%	14%	0.144	0.958	2.06	1.84	5	6	0	0	100%	1
6EHH_2GE_B_201	66%	12%	0.136	0.942	2.11	1.96	7	6	0	0	100%	1
6EHH_2GE_A_201	56%	13%	0.16	0.931	2.07	1.85	7	7	0	0	100%	1
5MZG_2GE_A_201	96%	27%	0.067	0.975	1.28	1.65	2	4	0	0	100%	1
5HZX_2GE_B_201	92%	21%	0.079	0.968	1.14	2.17	4	7	0	0	100%	1
4N1U_2GE_B_201	67%	14%	0.1	0.906	1.29	2.57	2	12	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.